Motley Fool  Jul 11  Comment 
Amarin Plc has important catalysts that investors ought to know about before buying its shares.
Forbes  Jul 10  Comment 
The Federal government continues to fight drug company efforts to talk about clinical information, rather than issue clarifying guidelines that could reconcile its regulatory prerogative with the First Amendment and the interests of doctors and...
FiercePharma  Jun 10  Comment 
Pharma marketers are closely watching Amarin's lawsuit demanding the right to talk up the off-label uses for its cardiovascular drug Vascepa. After all, if the legal attack against FDA regulations succeeds, that gives credence to drugmakers'...
FiercePharma  May 29  Comment 
Amarin has finally grabbed the 5-year marketing exclusivity for fish oil pill Vascepa that it's long been seeking.
Motley Fool  May 28  Comment 
A court decision is sparking enthusiasm for this maker of the triglyceride lowering drug Vascepa.
Forbes  May 28  Comment 
Pharma company Amarin's lawsuit claiming that an FDA decision violates its First Amendment right of free speech is simply an effort to circumvent the US drug approval process.
TheStreet.com  May 28  Comment 
NEW YORK (TheStreet) -- Shares of Amarin Pharmaceuticals  are surging higher after a U.S. district court sided with the company in its challenge of the Food and Drug Administration’s determination that Amarin’s new drug, Vascepa, is not...



This is a test No its not

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki